Can a simple blood test and AI catch cancer before it spreads?

NCT ID NCT06717295

Recruiting now Knowledge-focused Sponsor: Javier Toledo Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated May 13, 2026 · Updated 24 times

Summary

This study is developing an AI-powered blood test to find cancer early and see how well treatments are working. Researchers will analyze blood samples from 6,000 adults with or without cancer to identify unique RNA signals in platelets and immune cells. The goal is a safe, non-invasive tool that could improve cancer diagnosis and care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Babraham Research Institute
ENROLLING_BY_INVITATION

Cambridge, CB22 3AT, United Kingdom
Dysplasia Diagnostics Limited
RECRUITING

London, W1W 7LT, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
NSIA- Lagos University Teaching Hospital Cancer Centre
RECRUITING

Lagos, Nigeria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••
Various Cancer Centres
ACTIVE_NOT_RECRUITING

Rosario, Argentina

Conditions

Explore the condition pages connected to this study.

BREST CANCER COLORECTAL CANCER GLIOBLASTOMA (GBM) LIVER CARCINOMA LUNG CANCER (NSCLC) OVARIAN CANCER PANCREATIC CANCER, ADULT PROSTATE CANCERS PROSTATE CANCERS